Tag: PHARMA NEWS
Argenx’s Efgartigimod Clears Phase 3, Bringing New Hope for Autoimmune Myositis
argenx SE (Euronext & Nasdaq: ARGX) reported on August 17 that its Phase 3 ALKIVIA trial of subcutaneous efgartigimod (marketed as VYVGART Hytrulo) achieved its primary goal in...
Pfizer-Valneva Lyme Vaccine Clears Key EU Regulatory Step
Pfizer Inc. and Valneva SE announced that the European Medicines Agency has formally accepted for review the Marketing Authorization Application for their jointly developed Lyme disease...
Telangana Government Merges Food Safety and Drugs Control Departments to Form Unified Authority ‘TG SAFE’
In a major regulatory and administrative reform, the Government of Telangana has merged the Food Safety Department and the Drugs Control Department into a...
Caplin Point Laboratories Signs ₹925 Crore MoU to Establish Four New Manufacturing Units in Tamil Nadu
Caplin Point Laboratories Ltd has signed a Memorandum of Understanding (MoU) committing an investment of ₹925 crore to establish four new state-of-the-art pharmaceutical manufacturing...
New Genomic Study Reveals Origin of DRC’s Ebola Outbreak
A new genomic analysis published in Nature Medicine has identified the cause of the Ebola outbreak sweeping the Democratic Republic of the Congo (DRC):...
Blue Jet Healthcare Inaugurates Advanced R&D Centre in Hyderabad to Accelerate Green Chemistry and Pharmaceutical Innovation
Blue Jet Healthcare Ltd, a prominent global contract development and manufacturing organization (CDMO), has officially inaugurated its state-of-the-art Research and Development (R&D) Centre in...
